z-logo
Premium
Immunomodulatory and clinical effects of daratumumab in T‐cell acute lymphoblastic leukaemia
Author(s) -
Cerrano Marco,
Castella Barbara,
Lia Giuseppe,
Olivi Matteo,
Faraci Danilo G.,
Butera Sara,
Martella Federica,
Scaldaferri Matilde,
Cattel Francesco,
Boccadoro Mario,
Massaia Massimo,
Ferrero Dario,
Bruno Benedetto,
Giaccone Luisa
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16960
Subject(s) - daratumumab , medicine , blinatumomab , minimal residual disease , oncology , multiple myeloma , cd38 , immunology , t cell , hematology , bone marrow , immune system , stem cell , bortezomib , cd34 , cd19 , biology , genetics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here